Bamifylline
- [[File:{{Bamifylline.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]
WikiDoc Resources for Bamifylline |
Articles |
---|
Most recent articles on Bamifylline Most cited articles on Bamifylline |
Media |
Powerpoint slides on Bamifylline |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Bamifylline at Clinical Trials.gov Clinical Trials on Bamifylline at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Bamifylline
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Bamifylline Discussion groups on Bamifylline Patient Handouts on Bamifylline Directions to Hospitals Treating Bamifylline Risk calculators and risk factors for Bamifylline
|
Healthcare Provider Resources |
Causes & Risk Factors for Bamifylline |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Bamifylline is a drug of the xanthine chemical class which acts as a selective adenosine A1 receptor antagonist.[1][2]
See also
References
- ↑ Tomai F, Crea F, Gaspardone A, Versaci F, De Paulis R, Polisca P, Chiariello L, Gioffrè PA (June 1996). "Effects of A1 adenosine receptor blockade by bamiphylline on ischaemic preconditioning during coronary angioplasty". European Heart Journal. 17 (6): 846–53. doi:10.1093/oxfordjournals.eurheartj.a014965. PMID 8781823.
- ↑ PMID 6752929 (PMID 6752929)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand